This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Introduction

David J. Kupfer, M.D.

Published: January 1, 1997

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Depressive illness is common in the general population and is associatedwith significant morbidity, mortality, and societal costs. Although specific pharmacologic and psychotherapeutic interventions have been found to be effective in treating major depression, only a minority of individuals with depression currently receive such treatments; this undertreatment is due in part to lack of recognition and diagnosis of depression and in part to provision of inadequate treatment even when depression is correctly diagnosed.

‘ ‹’ ‹’ ‹’ ‹’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 58

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...